Metropolitan Life Insurance Company (MetLife)’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,632
| Closed | -$9.22K | – | 1860 |
|
|
2024
Q1 | $9.22K | Buy |
1,632
+546
| +50% | +$3.09K | ﹤0.01% | 2158 |
|
|
2023
Q4 | $4.66K | Sell |
1,086
-1,867
| -63% | -$8.01K | ﹤0.01% | 2290 |
|
|
2023
Q3 | $10.2K | Hold |
2,953
| – | – | ﹤0.01% | 2192 |
|
|
2023
Q2 | $13.7K | Hold |
2,953
| – | – | ﹤0.01% | 2128 |
|
|
2023
Q1 | $13.6K | Sell |
2,953
-28
| -0.9% | -$129 | ﹤0.01% | 2048 |
|
|
2022
Q4 | $24.1K | Hold |
2,981
| – | – | ﹤0.01% | 1907 |
|
|
2022
Q3 | $16.5K | Buy |
2,981
+2,604
| +691% | +$14.5K | ﹤0.01% | 2116 |
|
|
2022
Q2 | $1.96K | Sell |
377
-2,570
| -87% | -$13.4K | ﹤0.01% | 2359 |
|
|
2022
Q1 | $24.2K | Sell |
2,947
-6,886
| -70% | -$56.6K | ﹤0.01% | 2003 |
|
|
2021
Q4 | $146K | Sell |
9,833
-2,877
| -23% | -$42.8K | ﹤0.01% | 2237 |
|
|
2021
Q3 | $240K | Buy |
12,710
+679
| +6% | +$12.8K | ﹤0.01% | 1937 |
|
|
2021
Q2 | $224K | Buy |
12,031
+3,393
| +39% | +$63.1K | ﹤0.01% | 2063 |
|
|
2021
Q1 | $197K | Hold |
8,638
| – | – | ﹤0.01% | 2031 |
|
|
2020
Q4 | $188K | Hold |
8,638
| – | – | ﹤0.01% | 1978 |
|
|
2020
Q3 | $86.8K | Buy |
+8,638
| New | +$86.8K | ﹤0.01% | 2294 |
|